HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nana Takagi Selected Research

2- (4- (2- (diethylamino)ethoxy)phenyl)- N- (2,4- difluorobenzyl)- 5- fluoropyrimidin- 4- amine

1/2010RS-1748, a novel CC chemokine receptor 4 antagonist, inhibits ovalbumin-induced airway inflammation in guinea pigs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nana Takagi Research Topics

Disease

1Bone Diseases (Bone Disease)
01/2022
1Osteoporosis
01/2022
1Wasting Syndrome (Wasting Disease)
09/2021
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
09/2021
1Asthma (Bronchial Asthma)
01/2010
1Inflammation (Inflammations)
01/2010
1Arthritis (Polyarthritis)
03/2009

Drug/Important Bio-Agent (IBA)

1Parathyroid Hormone (Parathormone)IBA
01/2022
1Alendronate (Alendronate Sodium)FDA LinkGeneric
01/2022
1Antisense OligonucleotidesIBA
09/2021
1DystrophinIBA
09/2021
1Nonsense Codon (Nonsense Mutation)IBA
09/2021
1Proteins (Proteins, Gene)FDA Link
09/2021
1RNA Precursors (Precursor, mRNA)IBA
09/2021
1CCR4 ReceptorsIBA
01/2010
1OvalbuminIBA
01/2010
12- (4- (2- (diethylamino)ethoxy)phenyl)- N- (2,4- difluorobenzyl)- 5- fluoropyrimidin- 4- amineIBA
01/2010
1Collagen Type II (Type II Collagen)IBA
03/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2009

Therapy/Procedure

1Aftercare (After-Treatment)
01/2022
1Therapeutics
01/2022